Published in Lancet on September 02, 1989
Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol (2008) 1.87
Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res (2010) 1.65
Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci U S A (1996) 1.21
Antiglucocorticoid actions of dehydroepiandrosterone and low concentrations in Alzheimer's disease. Lancet (1989) 1.05
Cortisol and DHEA-S are associated with startle potentiation during aversive conditioning in humans. Psychopharmacology (Berl) (2005) 1.02
Role of androgens and the androgen receptor in remodeling of spine synapses in limbic brain areas. Horm Behav (2007) 1.01
Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial. J Am Geriatr Soc (2008) 0.91
Neurosteroids and GABA-A Receptor Function. Front Endocrinol (Lausanne) (2011) 0.82
Regulation of neurosteroid biosynthesis by neurotransmitters and neuropeptides. Front Endocrinol (Lausanne) (2012) 0.81
Dehydroepiandrosterone sulphate in Alzheimer disease. Lancet (1990) 0.79
Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice. PLoS One (2013) 0.78
Dehydroepiandrosterone and Alzheimer's disease. Lancet (1989) 0.77
Dehydroepiandrosterone sulphate in Alzheimer's disease. Lancet (1990) 0.75
The protein kinase complement of the human genome. Science (2002) 35.36
Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science (1981) 23.67
Complementary DNA sequencing: expressed sequence tags and human genome project. Science (1991) 19.42
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell (1993) 7.14
Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature (1995) 6.14
The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med (1996) 5.06
A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem (1979) 4.77
Trace polypeptides in cellular extracts and human body fluids detected by two-dimensional electrophoresis and a highly sensitive silver stain. Proc Natl Acad Sci U S A (1979) 4.11
Family members' attitudes toward telling the patient with Alzheimer's disease their diagnosis. BMJ (1996) 4.07
Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry (2006) 3.73
Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron (1999) 3.52
Neuronal pp60c-src contains a six-amino acid insertion relative to its non-neuronal counterpart. Science (1987) 3.35
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J (1997) 3.34
Gel protein stains: silver stain. Methods Enzymol (1984) 3.18
Development of the EURO-D scale--a European, Union initiative to compare symptoms of depression in 14 European centres. Br J Psychiatry (1999) 3.13
Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J (1997) 3.11
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem (1986) 2.95
Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol (1998) 2.94
Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc (1989) 2.83
Methods for increasing the resolution of two-dimensional protein electrophoresis. Anal Biochem (1988) 2.78
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology (1999) 2.51
Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am J Hum Genet (2001) 2.51
A rapid sensitive silver stain for polypeptides in polyacrylamide gels. Anal Biochem (1981) 2.42
The prevalence of specific psychiatric disorders in Puerto Rico. Arch Gen Psychiatry (1987) 2.37
Silver staining methods for polyacrylamide gel electrophoresis. Methods Enzymol (1983) 2.36
Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci (2007) 2.33
The significance of the incidental finding of basal ganglia calcification on computed tomography. J Neurol Neurosurg Psychiatry (1981) 2.30
Affinity generation of single-stranded DNA for dideoxy sequencing following the polymerase chain reaction. Anal Biochem (1989) 2.29
Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci U S A (1996) 2.27
State-dependent nature of the clock drawing task in geriatric depression. J Am Geriatr Soc (1995) 2.27
Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A (1998) 2.22
Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters. J Neurosci (2001) 2.19
Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci U S A (2001) 2.19
Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet (1996) 2.18
Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet (1999) 2.16
Principles and narrative in forensic psychiatry: toward a robust view of professional role. J Am Acad Psychiatry Law (2001) 2.13
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry (2003) 2.12
Bacterial virus gene expression in human cells. Nature (1971) 2.04
Organization of the human serotonin transporter gene. J Neural Transm Gen Sect (1994) 1.97
Fate of bacteriophage lambda in non-immune germ-free mice. Nature (1973) 1.96
Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav (2008) 1.94
Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem (1993) 1.93
Tyrosine phosphorylation of specific proteins after mitogen stimulation of chicken embryo fibroblasts. Mol Cell Biol (1983) 1.92
The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin. Cell (1995) 1.91
Platelet 5-HT uptake and release stopped rapidly by formaldehyde. Nature (1975) 1.84
Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors. AIDS Res Hum Retroviruses (2000) 1.82
Transmission of Chagas disease through renal transplantation: report of a case. Trans R Soc Trop Med Hyg (1990) 1.80
The cheetah is depauperate in genetic variation. Science (1983) 1.75
Depression symptoms in late life assessed using the EURO-D scale. Effect of age, gender and marital status in 14 European centres. Br J Psychiatry (1999) 1.75
Energy and coincidence time resolution measurements of CdTe detectors for PET. J Instrum (2013) 1.73
A genetic association for cigarette smoking behavior. Health Psychol (1999) 1.69
How do patients with Alzheimer's disease cope with their illness? A clinical experience report. J Am Geriatr Soc (1995) 1.68
Premortem diagnosis of Creutzfeldt-Jakob disease by cerebrospinal fluid analysis. Lancet (1996) 1.66
Maternal transmission in Huntington's disease. Lancet (1983) 1.64
A tumor promoter stimulates phosphorylation on tyrosine. Biochem Biophys Res Commun (1983) 1.62
A simple sequence repeat polymorphism at the human growth hormone locus. Nucleic Acids Res (1991) 1.60
Injury prevention. A new perspective. JAMA (1994) 1.60
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J (1998) 1.60
A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition. Gut (1999) 1.58
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science (1996) 1.56
Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Arch Gen Psychiatry (1987) 1.56
Baseball and beer: an analysis of alcohol consumption patterns among male spectators at major-league sporting events. Ann Emerg Med (1998) 1.55
Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav (2003) 1.54
The clinical dementia rating sum of box score in mild dementia. Dement Geriatr Cogn Disord (2005) 1.54
An architecture for naval telemedicine. IEEE Trans Inf Technol Biomed (1997) 1.52
Depression in Europe. Geographical distribution among older people. Br J Psychiatry (1999) 1.51
Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli. J Virol (2001) 1.50
Durable power of attorney and informed consent with Alzheimer's disease patients: a clinical study. Am J Psychiatry (1997) 1.50
Cross-cultural comparison of depressive symptoms in Europe does not support stereotypes of ageing. Br J Psychiatry (1999) 1.48
Differential diagnosis of dementia: a prospective evaluation of the DAT Inventory. J Am Geriatr Soc (1994) 1.47
Isolation of bacteriophages from commercial sera. In Vitro (1973) 1.47
Tetranucleotide repeat polymorphism at the human coagulation factor XIII A subunit gene (F13A1). Nucleic Acids Res (1991) 1.46
Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. J Neurosci (2000) 1.46
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Arch Gen Psychiatry (1990) 1.46
A double FDG/PET study of the effects of scopolamine in older adults. Neuropsychopharmacology (1994) 1.44
The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography. Arch Neurol (1991) 1.44
A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP. Biol Psychiatry (1993) 1.44
Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology (2001) 1.43
Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein. Mol Cell Biol (1999) 1.41
What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res (2007) 1.41
A functional anatomical study of associative learning in humans. Proc Natl Acad Sci U S A (1994) 1.40
Blood pressure and the risk for dementia: a double edged sword. Ageing Res Rev (2008) 1.40
Gas gangrene from subcutaneous insulin administration. Am J Emerg Med (1993) 1.39
Gel-staining techniques. Methods Enzymol (1990) 1.39
Older drivers and physicians. JAMA (1995) 1.38
Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal Biochem (1988) 1.38
Aging and mental health: primary care of the healthy older adult. A roundtable discussion: Part I. Geriatrics (1992) 1.37
Multiple rare SAPAP3 missense variants in trichotillomania and OCD. Mol Psychiatry (2009) 1.37
Effort and cognition in depression. Arch Gen Psychiatry (1982) 1.37
A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens. Br J Cancer (2012) 1.35
Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci (2001) 1.34
Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci (2001) 1.33
Genetic analysis of the herpes simplex virus type 1 UL9 gene: isolation of a LacZ insertion mutant and expression in eukaryotic cells. Virology (1992) 1.30
Multiple representations contribute to body knowledge processing. Evidence from a case of autotopagnosia. Brain (1991) 1.30
Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol Psychiatry (2000) 1.29